2016


To access this material please log in or register

Register Authorize
2016/№4

Rivaroxaban and left ventricle thrombus resolution in the patient with post-infarction cardiosclerosis

Rychkov A. Yu., Khorkova N. Yu., Yaroslavskaya E. I.
“Tyumen Cardiology Science Center”, Branch of the Federal State budgetary science institution, “Tomsk National research medical Center of the russian Academy of sciences”, Melnikaite 111, Tyumen 625026

Keywords: myocardial infarction, thrombosis, treatment, rivaroxaban

DOI: 10.18087/rhj.2016.4.2219

  1. Руда М. Я., Голицын С. П., Грацианский Н. А., Комаров А. Л., Панченко Е. П., Староверов И. И. и др. Национальные рекомендации по диагностике и лечению больных острым инфарктом миокарда с подъемом сегмента ST электрокардиограммы. Кардиоваскулярная терапия и профилактика. 2007;6 (8 Прил 1):415–500 [Ruda M. Ya., Goliczy`n S. P., Graczianskij N. A., Komarov A. L., Panchenko E. P., Staroverov I. I. i dr. Naczional`ny`e rekomendaczii po diagnostike i lecheniyu bol`ny`x ostry`m infarktom miokarda s pod``emom segmenta ST e`lektrokardiogrammy`. Kardiovaskulyarnaya terapiya i profilaktika. 2007;6 (8 Pril 1):415–500].
  2. Сулимов В. А., Голицын С. П., Панченко Е. П., Попов С. В., Ревишвили А. Ш., Щубик Ю. В., Явелов И. С. Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА и АССХ. Российский кардиологический журнал. 2013;4 (Прил 3):1–100 [Sulimov V. A., Goliczy`n S. P., Panchenko E. P., Popov S. V., Revishvili A. Sh., Shhubik Yu. V., Yavelov I. S. Diagnostika i lechenie fibrillyaczii predserdij. Rekomendaczii RKO, VNOA i ASSX. Rossijskij kardiologicheskij zhurnal. 2013;4 (Pril 3):1–100].
  3. Nakasuka K, Ito S, Noda T, Hasuo T, Sekimoto S, Ohmori H et al. Resolution of left ventricular thrombus secondary to tachycardia-induced heart failure with rivaroxaban. Case Rep Med. 2014;2014:814524.
  4. Padilla Perez M, Salas Bravo D, Garcelan Trigo JA, Vazquez Ruiz de Castroviejo E, Torres Llergo J, Lozano Cabezas C, Fernandez Guerrero JC. Resolution of left ventricular thrombus by rivaroxaban. Future Cardiol. 2014 May;10 (3):333–6.
  5. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2014 Jul;45 (7):2160–236.
  6. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012 Oct;33 (20):2569–619.
  7. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al. 2013 ACCF / AHA guideline for the mana­gement of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 29;127 (4):e362–425.
  8. Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P et al. Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice guidelines. Chest. 2012 Feb;141 (2 Suppl): e637S-68S.
  9. Hammerstingl C, Potzsch B, Nickenig G. Resolution of giant left atrial appendage thrombus with rivaroxaban. Thromb Haemost. 2013 Apr;109 (4):583–4.
  10. Takasugi J, Yamagami H, Okata T, Toyoda K, Nagatsuka K. Dis­solution of the left atrial appendage thrombus with rivaroxaban therapy. Cerebrovasc Dis. 2013;36 (4):322–3.
  11. Рычков А. Ю., Хорькова Н. Ю., Ярославская Е. И. Ривароксабан при тромбозе левого предсердия у пациента с трепетанием предсердий. Кардиология. 2014,54 (10):93–6 [Ry`chkov A. Yu., Xor`kova N. Yu., Yaroslavskaya E. I. Rivaroksaban pri tromboze levogo predserdiya u paczienta s trepetaniem predserdij. Kardiologiya. 2014,54 (10):93–6].
  12. Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B et al. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial / left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF). Am Heart J. 2015 Apr;169 (4):464–71.e2.
Rychkov A. Yu., Khorkova N. Yu., Yaroslavskaya E. I. Rivaroxaban and left ventricle thrombus resolution in the patient with post-infarction cardiosclerosis. Russian Heart Journal. 2016;15 (4):298–300

To access this material please log in or register

Register Authorize
Ru En